» Articles » PMID: 31277761

Laparotomy or Minimal Invasive Surgery in Uterus Transplantation: a Comparison

Overview
Journal Fertil Steril
Date 2019 Jul 7
PMID 31277761
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Uterus transplantation (UTx) is the first available treatment for absolute uterine factor infertility, a condition due to absence of the uterus or presence of a non-functional uterus. The proof-of-concept of UTx as an infertility treatment for this group of patients occurred in 2014 in Sweden by the first birth after human UTx. That and subsequent cases of the Swedish trial were live-donor UTx procedures with laparotomy of both donor and recipient. Although results of the initial Swedish clinical UTx trial were very favorable in terms of take-home-baby rate, the drawback was the long duration (>10 h) of donor surgeries and associated long recovery periods. There exist three later publications, with uterus procurements from live donors by laparotomy with a range of surgical durations of 5.3 hours to 13 hours. Our collaborative Swedish-French team has initiated efforts to introduce minimal invasive surgery in one trial in Sweden and one in France. The principle of these UTx trials is to use modern concepts of robotic-assisted laparoscopy primarily in the live donor. There also exists a small number of published UTx procedures with donor surgery by partial conventional laparoscopy and one published case with total robotic-assisted laparoscopy procedure. This review discusses open versus minimal invasive surgery in relation to the accumulated knowledge in the field. Moreover, we propose some future directions for the development of this surgery in UTx.

Citing Articles

Uterus Transplantation as a Surgical Innovation.

Perez-Blanco A, Seoane J, Pallas T, Nieto-Moro M, Calonge R, de la Fuente A J Bioeth Inq. 2023; 20(3):367-378.

PMID: 37382845 PMC: 10624705. DOI: 10.1007/s11673-023-10272-5.


Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS).

Brucker S, Kramer B, Abele H, Henes M, Hoopmann M, Scholler D Arch Gynecol Obstet. 2022; 307(3):827-840.

PMID: 36342536 PMC: 9984324. DOI: 10.1007/s00404-022-06796-7.


Analysis of Predictive Factors for Successful Vascular Anastomoses in a Sheep Uterine Transplantation Model.

Le Gal C, Carbonnel M, Balaya V, Richard C, Gelin V, Galio L J Clin Med. 2022; 11(18).

PMID: 36142908 PMC: 9503062. DOI: 10.3390/jcm11185262.


Costimulation Blockade in Vascularized Composite Allotransplantation.

Giannis D, Moris D, Cendales L Front Immunol. 2020; 11:544186.

PMID: 33042138 PMC: 7527523. DOI: 10.3389/fimmu.2020.544186.


Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: a comprehensive update.

Herlin M, Petersen M, Brannstrom M Orphanet J Rare Dis. 2020; 15(1):214.

PMID: 32819397 PMC: 7439721. DOI: 10.1186/s13023-020-01491-9.